Suchergebnisse - "Second line"

PubPharm (3.004)

1

The Effect and Safety of Flumatinib in Patients with Chronic Myelogenous Leukemia Failed First-and Second-line Treatment

enthalten in: Zhongguo shi yan xue ye xue za zhi | 2024

von Liu, L. | Wei, J. | Jia, T. | +2

2

Front-line and second-line treatment for mantle cell lymphoma in clinical practice : A multicenter retrospective analysis

enthalten in: European journal of haematology | 2024

von Harmanen, M. | Sorigue, M. | Khan, M. | +12

3

Efficacy and biomarker analysis of second-line nab-paclitaxel plus sintilimab in patients with advanced biliary tract cancer

enthalten in: Cancer science | 2024

von Li, X. | Zhou, N. | Yang, Y. | +2

4

Epidemiology of first- and second-line drugs-resistant pulmonary tuberculosis in Iran : Systematic review and meta-analysis

enthalten in: Journal of clinical tuberculosis and other mycobacterial diseases | 2024

von Abbasian, S. | Heidari, H. | Abbasi Tadi, D. | +6

5

Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea : A Systematic Literature Review

enthalten in: Advances in therapy | 2024

von Zhang, X. | Zhou, L. | Zhou, C. | +1

6

Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies : A systematic review and Bayesian network analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Xiong, X. | Zhang, S. | Zheng, W. | +6

7

Apatinib Plus Toripalimab (Anti-PD1 Therapy) as Second-Line Therapy in Patients With Advanced Gastric or Esophagogastric Junction Cancer : Results From a Randomized, Open-Label Phase II Study

enthalten in: The oncologist | 2024

von Wei, Q. | Xu, X. | Li, J. | +12

8

Second-line treatment strategies for RAS wild-type colorectal cancer : A systematic review and Network Meta-analysis (NMA)

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Di Nardo, P. | Basile, D. | Siciliano, A. | +13

9

Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinoma

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2024

von Yoon, H. | Shin, Y. | Ryoo, B. | +17

10

Efficacy and safety analysis of immune checkpoint inhibitor rechallenge therapy in locally advanced and advanced non-small cell lung cancer : a retrospective study

enthalten in: Journal of thoracic disease | 2024

von Yan, X. | Zhao, L. | Wu, F. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[301]